What is the primary purpose of the new Executive Officer Performance Excellence Program?

The primary purpose of the Executive Officer PEP is to align the compensation of HCA Healthcare's executive officers directly with the achievement of specific financial (EBITDA) and operational quality targets for 2025. This program is designed to incentivize strong company performance in both profitability and patient care.

How is executive compensation structured under this new program?

Executive compensation is determined by performance against specified targets. The award opportunity is weighted 80% towards achieving EBITDA targets and 20% towards meeting defined quality metrics. The potential payout for each component can range from a minimum threshold to a maximum level.

What are the key quality metrics that executive compensation is tied to?

The quality metrics are categorized as follows: Healthcare-Associated Infections and Sepsis (30% weighting within the quality component), Complication and Mortality (30%), and Care Experience (40%).

Are there any conditions that could prevent executives from receiving payouts on quality performance?

Yes, a significant condition is that if the company's actual EBITDA performance is less than 90% of the target EBITDA level, then there will be no payment made with respect to the quality-weighted portion of the Executive Officer PEP. This ensures financial performance is a prerequisite for quality-based awards.

HCA 8-K: Leadership Changes

Summary

HCA Healthcare, Inc. (HCA) has filed an 8-K report detailing its 2025 Executive Officer Performance Excellence Program (Executive Officer PEP). This new program outlines the performance-based compensation structure for the company's executive officers, aiming to align their incentives with key financial and operational goals. The program emphasizes achievement of EBITDA targets, which represent 80% of the award opportunity, and quality metrics, accounting for the remaining 20%. This structure suggests a strong focus on profitability and operational efficiency, while also incorporating critical quality of care indicators as defined by the company. For investors, the most significant aspect is the direct link between executive compensation and the achievement of specific financial and quality benchmarks. The program details the potential payout percentages based on performance levels, ranging from threshold to maximum achievement, with specific award opportunities tied to base salary for the CEO, CFO, and COO. The inclusion of stringent conditions, such as a minimum EBITDA performance being required for any quality-based payout, underscores the company's commitment to balancing financial success with patient care excellence. The filing also notes the retirement of a Board member, Meg G. Crofton, effective at the upcoming annual meeting.

Key Highlights

1HCA Healthcare has established the 2025 Executive Officer Performance Excellence Program (Executive Officer PEP) to determine executive compensation based on performance.
2Executive compensation under the PEP is weighted 80% on EBITDA targets and 20% on quality metrics.
3Quality metrics are segmented into Healthcare-Associated Infections and Sepsis (30%), Complication and Mortality (30%), and Care Experience (40%).
4CEO Samuel N. Hazen has a target award opportunity of 175% of base salary.
5EVP & CFO Michael A. Marks and EVP & COO Jon M. Foster have target award opportunities of 125% of base salary.
6Payouts for EBITDA performance range from 25% for threshold to 200% for maximum achievement, relative to the target award.
7A critical condition is that no payment will be made for the quality-weighted portion if actual EBITDA falls below 90% of the target level.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Feb 24, 2025)

Summary

Key Highlights

Frequently Asked Questions